Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes-the HOSMIDIA study

International Journal of Clinical Practice

Volumn 68, Issue 10, 2014, Pages 1264-1271

  Perez A ^a   Reales, P ^b   Barahona, M J ^c   Romero, M G ^d   Minambres I ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Hospital Gutierrez Ortega   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d Centro de Investigation Basica Sanofi Aventis   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

AGED; ARTICLE; BASAL BOLUS INSULIN; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; TREATMENT DURATION; ANALYSIS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84908208822     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12498     Document Type: Article

References (31)

1. Whiting DR, Guariguata L, Weil C, Shaw J,. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-21.
2. Jiang HJ, Stryer D, Friedman B, Andrews R,. Multiple hospitalizations for patients with diabetes. Diabetes Care 2003; 26: 1421-6.
3. Donnan PT, Leese GP, Morris AD, et al. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care 2000; 23: 1774-9.
4. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36 (Suppl. 1): S11-66.
5. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-31.
6. McDonnell ME, Umpierrez GE,. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am 2012; 41: 175-201.
7. Budnitz DS, Lovegrove MC, Shehab N, Richards CL,. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-12.
8. Schnipper JL, Magee M, Larsen K, et al. Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts. J Hosp Med 2008; 3 (5 Suppl.): 66-75.
9. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 16-38.
10. Murad MH, Coburn JA, Coto-Yglesias F, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012; 97: 49-58.
11. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-91.
12. Perez AP, Gutierrez PC, Diosdado MA, et al. Hospital treatment of hyperglycemia. Endocrinol Nutr 2009; 56: 303-16.
13. Umpierrez GE, Smiley D, Hermayer K, et al. Randomized study comparing a basal bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care 2013; 36: 2169-74.
14. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011; 34: 256-61.
15. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007; 30: 2181-6.
16. Schroeder JE, Liebergall M, Raz I, et al. Benefits of a simple glycaemic protocol in an orthopaedic surgery ward: a randomized prospective study. Diabetes Metab Res Rev 2012; 28: 71-5.
17. Umpierrez GE, Hor T, Smiley D, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 564-9.
18. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML,. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009; 32: 1153-7.
19. Montero Perez-Barquero M, Martinez Fernandez R, de Los Martires Almingol I, et al. Prognostic factors in patients admitted with type 2 diabetes in Internal Medicine Services: hospital mortality and readmission in one year (DICAMI study). Rev Clin Esp 2007; 207: 322-30.
20. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-82.
21. Capes SE, Hunt D, Malmberg K, Gerstein HC,. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-8.
22. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-32.
23. Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37: 3001-9.
24. Kosiborod M, Inzucchi SE, Spertus JA, et al. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation 2009; 119: 1899-907.
25. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-86.
26. Kwon S, Hermayer KL,. Glucocorticoid-induced hyperglycemia. Am J Med Sci 2013; 345: 274-7.
27. Saigi I, Perez A,. Management of glucocorticoid induced hyperglycemia. Rev Clin Esp 2010; 210: 397-403.
28. Perez Perez A, Gomez Huelgas R, Alvarez Guisasola F, et al. Consensus document on the management after hospital discharge of patient with hyperglycaemia. Med Clin (Barc) 2012; 138: 666 e1-e10.
29. Lipska KJ, Wang Y, Kosiborod M, et al. Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes. Circ Cardiovasc Qual Outcomes 2010; 3: 236-42.
30. Griffith ML, Boord JB, Eden SK, Matheny ME,. Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus. J Clin Endocrinol Metab 2012; 97: 2019-26.
31. Wexler DJ, Beauharnais CC, Regan S, et al. Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge. Diabetes Res Clin Pract 2012; 98: 249-56.